This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Erythromycin

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The antibacterial spectrum of erythromycin is similar to that of penicillin and it therefore provides an alternative in penicillin hypersensitive patients. It acts by inhibition of bacterial protein synthesis by binding to 50S ribosomal subunits.

Caution:

  • hepatic impairment

Contra-indication:

  • porphyria

Side-effects:

  • diarrhoea
  • cholestatic jaundice if give for more than 14 days
  • nausea and vomiting
  • sensorineural deafness when given in high doses, or to patients with renal or hepatic failure

Routes of administration:

  • oral:
    • tablets, capsules, mixture, suspension or granules
    • a standard dose is 250-500 mg every 6 hr
  • i.v. infusion:
    • 25-50 mg/kg daily

The summary of product characteristics must be consulted before prescribing this drug.

Reference:

  1. Drug and Therapeutics Bulletin 1995;33 (10): 76-8.
  2. Current Problems in Pharmacovigilance 2006;31:1-12.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.